MS

Maximizing Returns – Analyzing the Potential of MS Stock for Investors

A strong performer from today's morning trading session is Morgan Stanley, whose shares rose 1.1% to $80.81 per share. For those of you thinking about investing in the stock, here is a brief value analysis of the stock using the company's basic fundamental ratios.

Morgan Stanley Is Fairly Valued:

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 14.34 and an average price to book (P/B) ratio of 1.57. In contrast, Morgan Stanley has a trailing 12 month P/E ratio of 14.2 and a P/B ratio of 1.46.

Morgan Stanley's PEG ratio is 2.83, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

The Business Has Operating Margins Consistently Higher Than the 0.41% industry Average:

2017-02-27 2018-02-27 2019-02-26 2020-02-27 2021-02-26 2022-02-24
Revenue (MM) $34,631 $37,945 $40,107 $41,538 $48,757 $59,755
Operating Margins 26% 27% 28% 27% 30% 33%
Net Margins 17% 16% 22% 22% 23% 25%
Net Income (MM) $5,979 $6,111 $8,748 $9,042 $10,996 $15,034
Earnings Per Share $2.92 $3.07 $4.73 $5.19 $6.47 $8.16
EPS Growth n/a 5.14% 54.07% 9.73% 24.66% 26.12%
Diluted Shares (MM) 1,887 1,821 1,738 1,640 1,624 1,785
Free Cash Flow (MM) $6,659 -$2,876 $9,170 $42,599 -$23,787 $36,279
Capital Expenditures (MM) -$1,276 -$1,629 -$1,865 -$1,826 -$1,444 -$2,308
Long Term Debt (MM) $165,716 $192,582 $189,662 $192,627 $217,079 $233,127

Morgan Stanley has weak revenue growth and a flat capital expenditure trend, irregular cash flows, and an average amount of debt. We also note that the company benefits from strong margins with a stable trend and a strong EPS growth trend. Furthermore, Morgan Stanley's financial statements do not display any obvious red flags.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS